カテゴリー： Market Monitor Global, 世界, 医療/バイオ

組換え凝固第IX因子の世界市場見通し2023年-2029年

◆英語タイトル：Recombinant Coagulation Factor IX Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8628 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：76 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Recombinant Coagulation Factor IX Market 調査レポートは次の情報を含め、グローバルにおけるの組換え凝固第IX因子市場規模と予測を収録しています。・世界の組換え凝固第IX因子市場：売上、2018年-2023年、2024年-2029年
・世界の組換え凝固第IX因子市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の組換え凝固第IX因子市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「500IU」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

組換え凝固第IX因子のグローバル主要企業は、Pfizer、 Rebinyn、 CSL Behring、 Takeda、 Sanofi、 Aptevo Bio Therapeutics、 Thermo Fisherなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、組換え凝固第IX因子のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の組換え凝固第IX因子市場：タイプ別、2018年-2023年、2024年-2029年
世界の組換え凝固第IX因子市場：タイプ別市場シェア、2022年
・500IU、1000IU、その他

世界の組換え凝固第IX因子市場：用途別、2018年-2023年、2024年-2029年
世界の組換え凝固第IX因子市場：用途別市場シェア、2022年
・大人、子供

世界の組換え凝固第IX因子市場：地域・国別、2018年-2023年、2024年-2029年
世界の組換え凝固第IX因子市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における組換え凝固第IX因子のグローバル売上、2018年-2023年
・主要企業における組換え凝固第IX因子のグローバル売上シェア、2022年
・主要企業における組換え凝固第IX因子のグローバル販売量、2018年-2023年
・主要企業における組換え凝固第IX因子のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Rebinyn、 CSL Behring、 Takeda、 Sanofi、 Aptevo Bio Therapeutics、 Thermo Fisher

*************************************************************

・調査・分析レポートの概要
組換え凝固第IX因子市場の定義
市場セグメント
世界の組換え凝固第IX因子市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の組換え凝固第IX因子市場規模
世界の組換え凝固第IX因子市場規模：2022年 VS 2029年
世界の組換え凝固第IX因子市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの組換え凝固第IX因子の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の組換え凝固第IX因子製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：500IU、1000IU、その他
組換え凝固第IX因子のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
組換え凝固第IX因子の用途別グローバル売上・予測

・地域別市場分析
地域別組換え凝固第IX因子市場規模 2022年と2029年
地域別組換え凝固第IX因子売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Rebinyn、 CSL Behring、 Takeda、 Sanofi、 Aptevo Bio Therapeutics、 Thermo Fisher
...

This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor IX. This report contains market size and forecasts of Recombinant Coagulation Factor IX in global, including the following market information:
Global Recombinant Coagulation Factor IX Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Coagulation Factor IX Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Recombinant Coagulation Factor IX companies in 2022 (%)
The global Recombinant Coagulation Factor IX market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
500 IU Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Coagulation Factor IX include Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Coagulation Factor IX manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Coagulation Factor IX Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Type, 2022 (%)
500 IU
1000 IU
Other
Global Recombinant Coagulation Factor IX Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Application, 2022 (%)
Adult
Children
Global Recombinant Coagulation Factor IX Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Coagulation Factor IX revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Coagulation Factor IX revenues share in global market, 2022 (%)
Key companies Recombinant Coagulation Factor IX sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Coagulation Factor IX sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
Thermo Fisher
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Coagulation Factor IX, market overview.
Chapter 2: Global Recombinant Coagulation Factor IX market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Coagulation Factor IX capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Recombinant Coagulation Factor IX Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Coagulation Factor IX Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Coagulation Factor IX Overall Market Size
2.1 Global Recombinant Coagulation Factor IX Market Size: 2022 VS 2029
2.2 Global Recombinant Coagulation Factor IX Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Coagulation Factor IX Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Coagulation Factor IX Players in Global Market
3.2 Top Global Recombinant Coagulation Factor IX Companies Ranked by Revenue
3.3 Global Recombinant Coagulation Factor IX Revenue by Companies
3.4 Global Recombinant Coagulation Factor IX Sales by Companies
3.5 Global Recombinant Coagulation Factor IX Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Coagulation Factor IX Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Coagulation Factor IX Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Coagulation Factor IX Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Coagulation Factor IX Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor IX Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Coagulation Factor IX Market Size Markets, 2022 & 2029
4.1.2 500 IU
4.1.3 1000 IU
4.1.4 Other
4.2 By Type – Global Recombinant Coagulation Factor IX Revenue & Forecasts
4.2.1 By Type – Global Recombinant Coagulation Factor IX Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Coagulation Factor IX Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Coagulation Factor IX Sales & Forecasts
4.3.1 By Type – Global Recombinant Coagulation Factor IX Sales, 2018-2023
4.3.2 By Type – Global Recombinant Coagulation Factor IX Sales, 2024-2029
4.3.3 By Type – Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Coagulation Factor IX Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Coagulation Factor IX Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Children
5.2 By Application – Global Recombinant Coagulation Factor IX Revenue & Forecasts
5.2.1 By Application – Global Recombinant Coagulation Factor IX Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Coagulation Factor IX Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Coagulation Factor IX Sales & Forecasts
5.3.1 By Application – Global Recombinant Coagulation Factor IX Sales, 2018-2023
5.3.2 By Application – Global Recombinant Coagulation Factor IX Sales, 2024-2029
5.3.3 By Application – Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Coagulation Factor IX Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Coagulation Factor IX Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Coagulation Factor IX Revenue & Forecasts
6.2.1 By Region – Global Recombinant Coagulation Factor IX Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Coagulation Factor IX Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Coagulation Factor IX Sales & Forecasts
6.3.1 By Region – Global Recombinant Coagulation Factor IX Sales, 2018-2023
6.3.2 By Region – Global Recombinant Coagulation Factor IX Sales, 2024-2029
6.3.3 By Region – Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Coagulation Factor IX Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Coagulation Factor IX Sales, 2018-2029
6.4.3 US Recombinant Coagulation Factor IX Market Size, 2018-2029
6.4.4 Canada Recombinant Coagulation Factor IX Market Size, 2018-2029
6.4.5 Mexico Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Coagulation Factor IX Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Coagulation Factor IX Sales, 2018-2029
6.5.3 Germany Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.4 France Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.5 U.K. Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.6 Italy Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.7 Russia Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Coagulation Factor IX Market Size, 2018-2029
6.5.9 Benelux Recombinant Coagulation Factor IX Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Coagulation Factor IX Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Coagulation Factor IX Sales, 2018-2029
6.6.3 China Recombinant Coagulation Factor IX Market Size, 2018-2029
6.6.4 Japan Recombinant Coagulation Factor IX Market Size, 2018-2029
6.6.5 South Korea Recombinant Coagulation Factor IX Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Coagulation Factor IX Market Size, 2018-2029
6.6.7 India Recombinant Coagulation Factor IX Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Coagulation Factor IX Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Coagulation Factor IX Sales, 2018-2029
6.7.3 Brazil Recombinant Coagulation Factor IX Market Size, 2018-2029
6.7.4 Argentina Recombinant Coagulation Factor IX Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Coagulation Factor IX Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Coagulation Factor IX Sales, 2018-2029
6.8.3 Turkey Recombinant Coagulation Factor IX Market Size, 2018-2029
6.8.4 Israel Recombinant Coagulation Factor IX Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Coagulation Factor IX Market Size, 2018-2029
6.8.6 UAE Recombinant Coagulation Factor IX Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Recombinant Coagulation Factor IX Major Product Offerings
7.1.4 Pfizer Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Rebinyn
7.2.1 Rebinyn Company Summary
7.2.2 Rebinyn Business Overview
7.2.3 Rebinyn Recombinant Coagulation Factor IX Major Product Offerings
7.2.4 Rebinyn Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.2.5 Rebinyn Key News & Latest Developments
7.3 CSL Behring
7.3.1 CSL Behring Company Summary
7.3.2 CSL Behring Business Overview
7.3.3 CSL Behring Recombinant Coagulation Factor IX Major Product Offerings
7.3.4 CSL Behring Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.3.5 CSL Behring Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Recombinant Coagulation Factor IX Major Product Offerings
7.4.4 Takeda Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Recombinant Coagulation Factor IX Major Product Offerings
7.5.4 Sanofi Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Aptevo Bio Therapeutics
7.6.1 Aptevo Bio Therapeutics Company Summary
7.6.2 Aptevo Bio Therapeutics Business Overview
7.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Major Product Offerings
7.6.4 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.6.5 Aptevo Bio Therapeutics Key News & Latest Developments
7.7 Thermo Fisher
7.7.1 Thermo Fisher Company Summary
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher Recombinant Coagulation Factor IX Major Product Offerings
7.7.4 Thermo Fisher Recombinant Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.7.5 Thermo Fisher Key News & Latest Developments
8 Global Recombinant Coagulation Factor IX Production Capacity, Analysis
8.1 Global Recombinant Coagulation Factor IX Production Capacity, 2018-2029
8.2 Recombinant Coagulation Factor IX Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Coagulation Factor IX Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Coagulation Factor IX Supply Chain Analysis
10.1 Recombinant Coagulation Factor IX Industry Value Chain
10.2 Recombinant Coagulation Factor IX Upstream Market
10.3 Recombinant Coagulation Factor IX Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Coagulation Factor IX Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Recombinant Coagulation Factor IX in Global Market
Table 2. Top Recombinant Coagulation Factor IX Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Coagulation Factor IX Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Coagulation Factor IX Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Coagulation Factor IX Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Coagulation Factor IX Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Coagulation Factor IX Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Coagulation Factor IX Product Type
Table 9. List of Global Tier 1 Recombinant Coagulation Factor IX Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor IX Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Coagulation Factor IX Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Coagulation Factor IX Sales (K Units), 2024-2029
Table 16. By Application – Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Coagulation Factor IX Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Coagulation Factor IX Sales (K Units), 2024-2029
Table 21. By Region – Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Coagulation Factor IX Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Coagulation Factor IX Sales (K Units), 2024-2029
Table 26. By Country - North America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Coagulation Factor IX Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Coagulation Factor IX Sales, (K Units), 2024-2029
Table 30. By Country - Europe Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Coagulation Factor IX Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Coagulation Factor IX Sales, (K Units), 2024-2029
Table 34. By Region - Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Coagulation Factor IX Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Coagulation Factor IX Sales, (K Units), 2024-2029
Table 38. By Country - South America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Coagulation Factor IX Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Coagulation Factor IX Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Recombinant Coagulation Factor IX Product Offerings
Table 48. Pfizer Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Rebinyn Company Summary
Table 51. Rebinyn Recombinant Coagulation Factor IX Product Offerings
Table 52. Rebinyn Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Rebinyn Key News & Latest Developments
Table 54. CSL Behring Company Summary
Table 55. CSL Behring Recombinant Coagulation Factor IX Product Offerings
Table 56. CSL Behring Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. CSL Behring Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Recombinant Coagulation Factor IX Product Offerings
Table 60. Takeda Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Recombinant Coagulation Factor IX Product Offerings
Table 64. Sanofi Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Aptevo Bio Therapeutics Company Summary
Table 67. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Offerings
Table 68. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Aptevo Bio Therapeutics Key News & Latest Developments
Table 70. Thermo Fisher Company Summary
Table 71. Thermo Fisher Recombinant Coagulation Factor IX Product Offerings
Table 72. Thermo Fisher Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Thermo Fisher Key News & Latest Developments
Table 74. Recombinant Coagulation Factor IX Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Recombinant Coagulation Factor IX Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Recombinant Coagulation Factor IX Production by Region, 2018-2023 (K Units)
Table 77. Global Recombinant Coagulation Factor IX Production by Region, 2024-2029 (K Units)
Table 78. Recombinant Coagulation Factor IX Market Opportunities & Trends in Global Market
Table 79. Recombinant Coagulation Factor IX Market Drivers in Global Market
Table 80. Recombinant Coagulation Factor IX Market Restraints in Global Market
Table 81. Recombinant Coagulation Factor IX Raw Materials
Table 82. Recombinant Coagulation Factor IX Raw Materials Suppliers in Global Market
Table 83. Typical Recombinant Coagulation Factor IX Downstream
Table 84. Recombinant Coagulation Factor IX Downstream Clients in Global Market
Table 85. Recombinant Coagulation Factor IX Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Coagulation Factor IX Segment by Type in 2022
Figure 2. Recombinant Coagulation Factor IX Segment by Application in 2022
Figure 3. Global Recombinant Coagulation Factor IX Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Coagulation Factor IX Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Coagulation Factor IX Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Coagulation Factor IX Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Coagulation Factor IX Revenue in 2022
Figure 9. By Type - Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Coagulation Factor IX Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Coagulation Factor IX Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Coagulation Factor IX Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 23. US Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 37. China Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Coagulation Factor IX Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Coagulation Factor IX by Region, 2022 VS 2029
Figure 54. Recombinant Coagulation Factor IX Industry Value Chain
Figure 55. Marketing Channels

※参考情報

組換え凝固第IX因子は、血友病Bの治療に使用される重要な医薬品の一つです。血友病Bは、血液凝固に必要な第IX因子が欠乏または機能不全になる遺伝性疾患であり、患者は出血傾向が高くなるため、治療には第IX因子の補充が不可欠です。組換え凝固第IX因子は、従来の血液由来の因子と比べて、感染症のリスクを大幅に低減できるという特徴を持っています。このような因子は、遺伝子工学技術を用いて作製され、主に中国やアメリカ合衆国、日本など、先進国で広く使用されています。

組換え凝固第IX因子の定義は、その名の通り、遺伝子組換え技術によって作り出された第IX因子の一種です。この因子は、細胞培養系や微生物を用いて生産されます。具体的には、ヒトの第IX因子をコードする遺伝子を大腸菌や哺乳類の細胞に導入し、その細胞が生産したタンパク質を収集・精製して作られます。これにより、合成した因子が純粋で、安全性の高いものになります。従来の血漿由来の因子製剤とは異なり、ウイルス等の感染リスクを排除できるため、患者への供給が安定しています。

組換え核酸タンパク質は、さまざまな特性を持ち、血友病B患者における治療効果や安全性に寄与しています。特に、従来の因子製剤と比較して、純度が高く、より少ない量で効果が得られるため、患者の経済的負担を軽減できます。また、組換え製剤は、免疫応答を引き起こすリスクが低いため、長期間にわたって使用することが可能です。

組換え凝固第IX因子には、いくつかの種類があり、主にその製造プロセスや由来に基づいて分類されます。一つは、単純な基質を用いて生産される製品で、これには、不要な副生成物が少なく、比較的高い純度を誇るものが含まれます。また、修飾型第IX因子、すなわち、PEG（ポリエチレングリコール）によって修飾された製剤もあります。PEG化により、因子の体内での半減期が延長され、効果が持続しやすくなるため、投与頻度を減少させることができます。

組換え凝固第IX因子は、主に血友病Bの治療に用いられ、患者の出血発作の予防や治療に寄与します。治療は、通常、定期的な投与によって行われ、患者は自宅で自己投与することが可能です。この自己管理が患者の生活の質を向上させ、通院負担を軽減する一因ともなっています。また、手術や外傷後の出血リスクがある場合にも、迅速に投与することで、大量出血を防ぐ効果が期待できます。

さらに、この因子は、血液凝固および血友病治療における基礎的な研究にも重要な役割を果たしています。組換え第IX因子と他の凝固因子との相互作用や、病態生理の解明のための研究が進んでおり、より効果的な治療法の開発へつながる可能性があります。また、血友病だけでなく、他の凝固異常に関連した病気の治療にも応用されることが期待されており、研究が進行しています。

関連技術については、遺伝子組換え技術の進展が注目されています。これにより、今後さらに新しい治療薬が開発され、さまざまな病態に対応できる可能性があります。特に、細胞培養技術やタンパク質工学の進歩は、高度な製剤開発に寄与しています。加えて、マイクロ流体技術やナノテクノロジーの応用も、新たな治療法の開発に寄与することでしょう。

このように、組換え凝固第IX因子は、血友病Bの治療において重要な役割を果たしているだけでなく、関連技術の進展とともにさらなる応用が期待される分野であります。引き続き、患者のニーズに応じた新しい製剤の開発や、より効率的な治療法の確立が求められています。安全性が高く、効果的な治療を提供することが、患者の生活の質を向上させ、社会全体の健康を支える一助となるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換え凝固第IX因子の世界市場見通し2023年-2029年(Recombinant Coagulation Factor IX Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

組換え凝固第IX因子の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp